Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Hcw Biologics Inc (HCWB)

14 + Investors. Track Smart Money conviction in HCWB. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
→ 0
Streak
1Q —
Buyers last Q
65%

Smart Money Signals — HCWB

Based on 14 hedge funds · latest filing: 2026 Q1 · updated quarterly

➡️

No change last quarter

last 6Q
The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.
📊

High ownership — 78% of 3.0Y peak

78% of all-time peak
14 funds currently hold this stock — 78% of the 3.0-year high of 18 funds (reached 2024 Q1). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 7% fewer funds vs a year ago

fund count last 6Q
1 fewer hedge funds hold HCWB compared to a year ago (-7% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟢

More buyers than sellers — 65% buying

11 buying6 selling
Last quarter: 11 funds were net buyers (6 opened a brand new position + 5 added to an existing one). Only 6 were sellers (0 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.
➡️

Steady new buyers — ~6 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 5 → 4 → 5 → 6. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
📌

Mixed — 29% long-term, 36% new

29% conviction (2yr+) 36% medium 36% new
Of the 14 current holders: 4 (29%) held >2 years, 5 held 1–2 years, and 5 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💎

Buying through price weakness — shares +3%, value -66%

Value
-66%
Shares
+3%
Last quarter: funds added +3% more shares while total portfolio value only changed -66%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
➡️

Steady discovery — ~6 new funds/quarter

4 → 5 → 4 → 5 → 6 new funds/Q
New funds entering each quarter: 5 → 4 → 5 → 6. Consistent flow of new institutional buyers without clear acceleration or slowdown.
📊

Mixed cohorts — 36% veterans, 43% new entrants

36% veterans 21% 1-2yr 43% new
Of 14 current holders: 5 (36%) held 2+ years, 3 held 1–2 years, 6 (43%) entered in the past year. Balanced distribution — some institutional memory, some recent momentum buyers.

Strong quality — 24% AUM from major funds

24% from top-100 AUM funds
7 of 14 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — HCWB

In 2026 Q1, 11 hedge funds were net buyers of HCWB (6 opened a new position, 5 added to an existing one), while 6 reduced or exited (6 sold completely) — a 65% buyer ratio, indicating clear institutional accumulation. 24% of total institutional value in HCWB is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: flat (entries and exits balanced). Total institutional holders: 14.

Hedge Fund Ownership: HCWB

How many hedge funds hold HCWB — quarterly history vs. share price
Quarterly hedge fund ownership of HCWB vs. share price

Market Analysis: HCWB

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: HCWB

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Hcw Biologics Inc (HCWB) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much HCWB has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 23d ago
HCWB
-33.0%
XLV
+0.5%

HCWB outperformed XLV by -33.5% since June 30, 2026.

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

3 top-rated funds 0 high-conviction
Consensus
2.6
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: HCWB
2026 Q2 Stats Unlock in 27 days 14 + Investors

Track Smart Money conviction in HCWB. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 14 14 -
13F Shares 450K 437K 2.96%
Total Value $144K $424K -66.08%
New Positions 6 5 +1
Increased Positions 5 3 +2
Closed Positions 6 1 +5
Reduced Positions 0 3 -3
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: HCWB

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

14 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in HCWB. Verified SEC 13F-HR filings.

QUARTER:
Top 12 HCWB holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Golden State Wealth Management, LLC 0.00% 10,000 $4K
2 Hrt Financial LP 0.00% 266,393 $95K
3 Tower Research Capital LLC (TRC) 0.00% 14,839 $5K
4 Citigroup Inc 0.00% 10,528 $4K
5 Citadel Advisors LLC 0.00% 26,083 $9K
6 Jane Street Group, LLC 0.00% 14,134 $5K
7 UBS Group AG 0.00% 9,221 $3K
8 Vanguard Fiduciary Trust Co 0.00% 1,903
9 Vanguard Capital Management LLC 0.00% 12,023 $4K
10 Wells Fargo & Company/Mn 0.00% 1,000
11 Osaic Holdings, INC. 0.00% 26
12 Northwestern Mutual Wealth Management Co 0.00% 2
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Hcw Biologics Inc (HCWB)

What does the Smart Money Trend signal show for HCWB?

No change last quarter: The number of hedge funds holding this stock didn't change last quarter. Neither a buying nor selling signal on its own — watch the next quarter for direction.

What is the institutional breadth score for HCWB?

More buyers than sellers — 65% buying: Last quarter: 11 funds were net buyers (6 opened a brand new position + 5 added to an existing one). Only 6 were sellers (0 trimmed + 6 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for HCWB holders?

Strong quality — 24% AUM from major funds: 7 of 14 holders rank in the top 100 by AUM, accounting for 24% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held HCWB?

Mixed — 29% long-term, 36% new: Of the 14 current holders: 4 (29%) held >2 years, 5 held 1–2 years, and 5 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Hcw Biologics Inc (HCWB) following the 2026 Q2 hedge fund 13F filings?

Since the quarter end (June 30, 2026), HCWB has gained -33.0% vs +0.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →